Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant H1N1 Neuraminidase Protein(Active)

Cat.No. : NA-484H
Product Overview : Recombinant H1N1 neuraminidase (ACP41107.1) (His36-Lys469) was expressed, the cell lysates are collected, and bio-activity was tested.
  • Specification
  • Gene Information
  • Related Products
Source : HEK293
Species : H1N1
Tag : N/A
Form : Lyophilized from sterile PBS, 0.6% Triton X-100, 7% Trehalose, 6% Mannitol, pH 7.4. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Bio-activity : Measured by its ability to cleave a fluorogenic substrate, 2'-(4-Methylumbelliferyl)-α-D-N-acetylneuraminic acid.
The specific activity is > 100 U.
The specific activity is > 200 U.
One unit is defined as the amount of enzyme required to cleave 1 nmole of 2'-(4-Methylumbelliferyl)-α-D-N-acetylneuraminic acid per minute at pH 7.5 at 37°C.
Molecular Mass : The recombinant influenza A H1N1 Neuraminidase comprises 434 amino acids and has a predicted molecular mass of 47.8 KDa.
Protein Length : His 36-Lys 469
Endotoxin : < 1.0 EU per μg of the protein as determined by the LAL method
Storage : Samples are stable for up to twelve months from date of receipt at -20°C to -80°C
Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution : It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4°C before opening to recover the entire contents.

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (5)

Ask a question
Are there NA protein-based therapies in clinical use? 05/01/2023

Yes, some RNA-based therapies target specific NA proteins for conditions like spinal muscular atrophy.

How do histones relate to epigenetic modifications and clinical outcomes? 08/07/2019

Changes in histone modifications can influence gene expression and contribute to various diseases.

How are NA proteins used in cancer research and treatment? 03/20/2019

NA proteins are studied to understand oncogenesis, and some drugs target NA protein interactions to treat cancer.

Can NA proteins be used for gene therapy? 07/18/2018

NA proteins can be involved in gene therapy strategies to manipulate gene expression for therapeutic purposes.

How are NA proteins involved in the regulation of cell cycle and cancer progression? 12/05/2016

NA proteins control the cell cycle, and dysregulation can contribute to uncontrolled cell growth seen in cancer.

Customer Reviews (3)

Write a review
Reviews
11/26/2020

    I highly recommend the NA protein for a variety of experimental applications.

    09/08/2019

      I enthusiastically recommend the NA protein to fellow researchers who seek an unparalleled product accompanied by dedicated customer assistance.

      11/16/2018

        the NA protein stands out for its exceptional quality, coupled with the outstanding technical support delivered by the manufacturer.

        Ask a Question for All NA Products

        Required fields are marked with *

        My Review for All NA Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /

        Stay Updated on the Latest Bioscience Trends